Kolexia
Rouanne Mathieu
Chirurgie urologique
Hôpital Foch
Suresnes, France
137 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la vessie urinaire Carcinomes Tumeurs de la prostate Carcinome transitionnel Métastase tumorale Invasion tumorale Récidive tumorale locale Métastase lymphatique Complications postopératoires

Industries

AstraZeneca
2 collaboration(s)
Dernière en 2019
Ferring
1 collaboration(s)
Dernière en 2019
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis.
Immunity   02 février 2024
Immune checkpoints are predominantly co-expressed by clonally expanded CD4 FoxP3 intratumoral T-cells in primary human cancers.
Journal of experimental & clinical cancer research : CR   06 décembre 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
European urology   17 octobre 2023
Probiotic-guided CAR-T cells for solid tumor targeting.
Science (New York, N.Y.)   12 octobre 2023
From mucosal infection to successful cancer immunotherapy.
Nature reviews. Urology   11 juillet 2023
Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity.
European journal of cancer (Oxford, England : 1990)   05 avril 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.
Cancer discovery   04 avril 2023
Rationale for LDH-targeted cancer immunotherapy.
European journal of cancer (Oxford, England : 1990)   14 décembre 2022
A machine-learning-based combination of criteria to detect bladder cancer lymph node metastasis on FFDG PET/CT: a pathology-controlled study.
European radiology   24 novembre 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.
Cancer discovery   06 octobre 2022